ArticleIndustrial psychiatry journal
Perspectives of opioid users on overdose recognition, naloxone administration, and attitudes.
Article in Industrial psychiatry journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There has been a rise in opioid overdose deaths, despite harm reduction efforts like naloxone distribution. Naloxone is effective but underused due to knowledge gaps and stigma. Aim: To assess opioid users' knowledge regarding overdose and attitudes, experiences toward naloxone. Materials and Methods: This cross-sectional study was conducted from August 2024 to May 2025 at a Deaddiction center. Participants with opioid use disorder were interviewed using a semistructured performa and the Brief Opioid Overdose Knowledge questionnaire to assess opioid users' knowledge and attitudes toward naloxone. Results: Our study involved 501 participants, mostly males (mean age = 27.16 years) with substance use averaging 6.5 years. Nearly half had overdose history, with serious outcomes common. Knowledge, overdose recognition, and overdose response scores varied significantly based on factors like history of overdose, awareness and use of naloxone, education, and socioeconomic status. Knowledge about naloxone was low, with mixed attitudes and significant barriers like stigma and poor access. Conclusion: Our study reveals that despite naloxone's proven efficacy in reversing opioid overdoses, its use is limited by stigma, poor awareness, and restricted access. Enhancing harm reduction education and destigmatization through tailored community interventions is vital to preventing overdose fatalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.